How to implement ‘access to medicine’ AND enhance economic performance:business model options for global access

Article English OPEN
Peukert, J. (Jürgen); Fuggenthaler, T. (Thomas); (2009)
  • Subject: Economics
    • ddc: ddc:330

‘Access to medicine’ or ‘global access’ is at the core heart of corporate responsibility for pharmaceutical companies. Corporate responsibility, however, is not restricted to a philanthropic dimension (such as donations), which is often referred to as corporate citizens... View more
Share - Bookmark